A comparative study of humidification and a nasal spray for the treatment of nasal symptoms experienced by patients using continuous positive airway pressure (CPAP) via a mask

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN75033377

Enrollment

Registered

2003-09-12

Start date

2002-12-01

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nervous System Diseases: obstructive sleep apnoea (OSA) Nervous System Diseases Obstructive sleep apnoea (OSA)

Interventions

32 patients will be recruited from new patients presenting with OSA who are to be treated with CPAP. The study arms are: 1. Nasal spray 2. Headed humidification

Eligibility

Inclusion criteria

Inclusion criteria: 32 patients will be recruited from new patients presenting with OSA who are to be treated with CPAP

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

Measure	Time frame
Patients' nasal symptoms will be assessed using a self-scored scale. This will determine baseline symptoms, the effects of CPAP and of nasal sprays/humidification	—

Secondary

Measure	Time frame
Not provided at time of registration	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026